Search results
TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up
Zacks via Yahoo Finance· 1 day agoTEVA reports mixed first-quarter results, missing estimates for earnings but beating the same for...
An Expert Talks About New Research on Migraine Treatments
Healthline· 18 hours agoNeurologist Dr. Susan Lee answers common questions about new treatments for migraine and where the...
Earnings call: Teva Pharmaceuticals reports growth and pipeline progress By Investing.com
Investing.com· 1 day agoFinancial highlights include a 5% revenue increase, a 12% rise in adjusted EBITDA, and an 18%...
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters via Yahoo Finance· 3 days agoTeva Pharmaceutical Industries said it was set to launch its long awaited biosimilar of AbbVie's...
Teva Pharma's Turnaround Story: How A Key Win Helped It Clinch A Five-Year High
Investor's Business Daily· 2 days agoHighly Rated Pharma Stock Meanwhile, sales of its generic drugs rose more than 6% globally to $2.29...
Why Is Teva Pharmaceutical Stock Trading Higher On Wednesday? - Teva Pharmaceutical Indus...
Benzinga· 2 days agoWednesday, Teva Pharmaceutical Industries Ltd TEVA and Medincell announced results from the efficacy...
Stocks making the biggest moves midday: Uber, Intel, Lyft, Shopify, Rivian and more
CNBC· 2 days agoThese are the stocks posting the largest moves in midday trading.
Teva Pharm Q1 profit misses estimates, revenue rises By Reuters
Investing.com· 3 days agoTeva Pharmaceutical Industries (NYSE:TEVA) reported a smaller than expected rise in first-quarter profit citing higher impairments of tangible assets, while sales of copycat medicines and its ...
Teva Pharma Gains on Q1 Revenue Beat
Investing.com· 3 days agoTeva Pharma Gains on Q1 Revenue Beat
Teva stock gains on trial win, Q1 beat (NYSE:TEVA)
Seeking Alpha· 3 days agoTeva Pharmaceutical (TEVA) stock posts record gains due to better-than-expected Q1 revenue and positive Phase 3 trial results for its schizophrenia drug....